General Information
Version
6.3
Revision date
2023-12-20
Product name
Fenbendazole Related Compound B
CAS No.
20367-38-8
REACH No
is
Emergency telephone
+(45)-69918573
Icons in SDS
Company Information
company name
Merck Life Science ApS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H360, H400, H410
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Germ cell mutagenicity, H340: May cause genetic defects. (Category 1A) Reproductive toxicity, (Category H360: May damage fertility or the unborn 1B) child. Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.
2.2 Label elements
Labelling
Signal word
Danger
Hazard statements
H340 May cause genetic defects. H360 May damage fertility or the unborn child. H410 Very toxic to aquatic life with long lasting effects. Restricted to professional users.
Precautionary statements
P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
